$893M
$1.02 Million
0.0% of portfolio
91,955
Q2 2025
Added 10.91%
$930M
$351,000
0.0% of portfolio
6,490
Q2 2025
Added 1.79%
$453M
$20,000
0.0% of portfolio
720
Q2 2025
New
$451M
$1,000
0.0% of portfolio
30
Q1 2025
Added 3.45%
$1.51B
$856,000
0.0% of portfolio
44,086
Q2 2025
Added 12.44%
$2.06B
$886,000
0.0% of portfolio
16,094
Q2 2025
Reduced 1.26%
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 34.51%
$4.7B
$52,000
0.0% of portfolio
2,432
Q2 2025
Added 134.52%
$2.73B
$39,000
0.0% of portfolio
767
Q2 2025
Reduced 14.3%
$908M
$271,000
0.0% of portfolio
23,150
Q2 2025
Reduced 20.66%
$1.66B
$302,000
0.0% of portfolio
50,327
Q2 2025
Added 0.25%
$445M
$8,000
0.0% of portfolio
820
Q2 2025
Added 72.27%
$0
$53,000
0.0% of portfolio
2,981
Q2 2025
Reduced 10.59%
$9.78B
$1.02 Million
0.0% of portfolio
36,794
Q2 2025
Reduced 43.77%
$3.79M
$0
0.0% of portfolio
21
Q3 2024
Reduced 99.67%
$1.92B
$347,000
0.0% of portfolio
4,024
Q2 2025
Reduced 2.0%
$581M
$189,000
0.0% of portfolio
12,709
Q2 2025
Added 23.6%
$324M
$3,000
0.0% of portfolio
841
Q1 2025
Reduced 24.17%
$910M
$415,000
0.0% of portfolio
18,959
Q2 2025
Added 8.93%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 54.2%
$0
$30,000
0.0% of portfolio
2,230
Q3 2023
New
Morgan Stanley Direct Lendin
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 57.73%
$0
$151,000
0.0% of portfolio
29,671
Q2 2025
Added 1.78%
$0
$30,000
0.0% of portfolio
4,000
Q3 2023
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 9.84%
-
$0
0.0% of portfolio
-
Q2 2025
Added 5.65%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 0.07%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 307.48%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 14.92%
Morgan Stanley Pathway Fds
-
$0
0.0% of portfolio
-
Q2 2025
Added 217.37%
Morgan Stanley Pathway Fds
-
$0
0.0% of portfolio
-
Q2 2025
Added 244.08%
$457M
$13,000
0.0% of portfolio
897
Q2 2025
Added 14.85%
$1.21B
$828,000
0.0% of portfolio
60,457
Q2 2025
Reduced 17.1%
$584M
$8,000
0.0% of portfolio
612
Q4 2024
Reduced 95.51%
$2.94B
$970,000
0.0% of portfolio
5,349
Q2 2025
Reduced 3.19%
$597M
$171,000
0.0% of portfolio
32,219
Q2 2025
Reduced 1.3%
$1.47B
$206,000
0.0% of portfolio
25,462
Q2 2025
Added 5.16%
$235M
$1,000
0.0% of portfolio
45
Q4 2024
Reduced 33.82%
$1.6B
$251,000
0.0% of portfolio
8,455
Q2 2025
Added 29.18%
$442M
$4,000
0.0% of portfolio
40
Q2 2025
Reduced 9.09%
$179M
$1,000
0.0% of portfolio
63
Q2 2025
Reduced 28.41%
$3.58B
$395,000
0.0% of portfolio
9,151
Q2 2025
Added 3.01%
$1.46B
$480,000
0.0% of portfolio
12,789
Q2 2025
Reduced 0.14%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 33.84%
$1.8B
$444,000
0.0% of portfolio
4,154
Q2 2025
Reduced 0.24%